Minerva Neurosciences (NERV) Other Non-Current Liabilities (2013 - 2026)

Minerva Neurosciences' Other Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $60.0 million for Q1 2026.

• Quarterly Other Non-Current Liabilities changed 0.0% year-over-year to $60.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $60.0 million, changed N/A from the prior year.
• Other Non-Current Liabilities was $60.0 million for Q1 2026 at Minerva Neurosciences, roughly flat from $60.0 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $86.6 million in Q2 2024 and bottomed at $60.0 million in Q3 2024.
• A 5-year average of $70.6 million and a median of $70.9 million in 2022 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2024 — Other Non-Current Liabilities rose 11.37% — and 2025, when it slumped 30.7%.
• Minerva Neurosciences' Other Non-Current Liabilities stood at $73.7 million in 2022, then advanced by 11.23% to $82.0 million in 2023, then decreased by 26.84% to $60.0 million in 2024, then changed by 0.0% to $60.0 million in 2025, then changed by 0.0% to $60.0 million in 2026.
• Business Quant data shows NERV's Other Non-Current Liabilities at $60.0 million in Q1 2026, $60.0 million in Q4 2025, and $60.0 million in Q3 2025.